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Legionella pneumophila  multiplies  in a  novel intracellular vacuole in mononu- 
clear phagocytes (1). In this paper, the interaction between this L. pneumophila- 
containing vacuole and host cell lysosomes is examined. 
Some  intracellular  pathogens,  such  as  Toxoplasma  gondii  (2),  Mycobacterium 
tuberculosis (3, 4), Mycobacterium microti (5), Chlamydia psittaci (6), and Encephalito- 
zoon cuniculi  (7,  8)  have  been  reported  to  inhibit  fusion  of phagosomes  with 
lysosomes. Others, such as Leishmania  (9-13) and Mycobacterium lepraemurium  (5), 
have been reported not to inhibit fusion, and they are apparently able to survive 
within the normally inhospitable milieu of the phagolysosome. Still other intra- 
cellular  pathogens  such  as  Trypanosoma  cruzi  have  been  shown  to  avoid  the 
unfavorable environment of the phagolysosome altogether by escaping into the 
host cell cytoplasm (14,  15). The host cells in these studies have almost invariably 
been mouse peritoneal macrophages or mouse cell lines. 
This paper demonstrates that (a) L. pneumophila  inhibits phagosome-lysosome 
fusion  in  human  monocytes. The L.  pneumophila-containing  vacuole does  not 
fuse with  either primary or secondary lysosomes; (b) this inhibition  is partially 
overcome by coating the bacteria with antibody or activating the monocytes; and 
(c) the inhibition is not influenced by inhibiting bacterial protein synthesis with 
erythromycin. 
Materials and Methods 
Media, Agar, and Human  Blood Mononuclear Cells.  Media,  agar,  and  human  blood 
mononuclear cells were obtained or prepared as described (1). No antibiotics were added 
to medium except where specifically indicated. 
Reagents.  Thorium dioxide (thorotrast) was produced by Fellows Testagar, Detroit, 
MI, but is no longer commercially available. Erythromycin base was prepared and stored 
as  described  (1).  Cytidine  5'-monophosphate,  sodium  salt,  was  obtained  from  Sigma 
Chemical Co., St. Louis, MO. Lead nitrate was obtained from Fisher Scientific Co., Fair 
Lawn, NJ. 
Sera.  Sera were obtained and stored as described (1).  Normal (nonimmune) human 
serum (type AB) with an indirect fluorescent antibody anti-L, pneumophila titer of <1:64 
was obtained from an adult donor not known to have had Legionnaires' disease.  Immune 
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human serum with an indirect fluorescent antibody anti-L, pneumophila titer of 1:4,096 
was obtained from an adult donor who had recently recovered from Legionnaires' disease. 
Complement was inactivated by heating the serum at 56°C for 30 min just before use. 
Bacteria.  L. pneumophila,  Philadelphia 1 strain, was cultured and prepared and, where 
indicated, formalin-killed, as described (1). 
Escherichia coli, serotype 09:K29:H-, strain Bi161-42, an encapsulated serum-resistant 
strain, was cultured and prepared for experiments as described (16), and resuspended in 
RPMI 1640 medium to 10  TM CFU/ml. 
Streptococcus pneumoniae, strain R6 (17), was obtained from Dr. Alexander Tomasz, The 
Rockefeller University. The bacteria were grown to mid-logarithmic phase in C medium 
and yeast extract generously prepared by Ms. Helene Fischer as described (18),  washed 
by centrifugation at  12,000 g, and resuspended in RPMI 1640 medium to 101° bacterial 
particles/ml. 
Assay for  Fusion of L.  pneumophila-containing  Vacuoles with Secondary Lysosomes Using 
Thorium Dioxide Labeling.  Mononuclear cells (12 X 106) were incubated in 35-mm plastic 
petri dishes in 2 ml RPMI 1640 medium containing 10% fresh normal human serum for 
1.5 h at 37°C in  5% CO2-95%  air to allow  monocytes to adhere.  The dishes  were then 
vigorously washed  to  remove  the  nonadherent  lymphocyte-enriched fraction  of the 
mononuclear cell population. The monocyte monolayers were then incubated for 20 h at 
37°C in  5%  CO2-95% air in  2  ml  RPMI  1640 medium containing  15%  fresh normal 
human  serum  and  either  12.5  or  6.25  ul  undiluted  thorium  dioxide/ml.  After  this 
incubation, the monocyte monolayers were washed three times with RPMI 1640 medium 
to remove unbound thorium dioxide and incubated at 37°C for an additional 3 h to allow 
the monocytes to ingest thorium dioxide adsorbed on the cell surface and to concentrate 
internalized  thorium  dioxide  in  secondary  lysosomes (4,  5).  The  cultures  were  then 
incubated with  10 '° live or formalin-killed L. pneumophila/mi  that had been pretreated 
with a source of complement alone (fresh normal human serum), 10  TM live L. pneumophila/ 
ml that had been pretreated  with a  source of antibody alone (heat-inactivated immune 
human serum), or 7.5 x  10  a live L. pneumophila/ml  that had been pretreated with a source 
of both  anti-L,  pneumophila  antibody and  complement (fresh  immune  human  serum). 
Other cultures were incubated with 101° live unencapsulated S. pneumoniae/ml  pretreated 
with a  source of complement (fresh  normal human serum) or  109 live encapsulated E. 
coli/ml  pretreated  with  a  source of both complement and  anti-E,  coli antibody (fresh 
normal human serum); the normal human serum used contains natural antibody to this 
strain  of E.  coli (16).  Pretreatment  consisted of incubating the bacteria  in  50%  of the 
serum preparation indicated for 10 min at 24°C, immediately before adding the bacteria 
to the monocyte cultures. The final concentration of serum in all cultures was 25%. The 
monocyte cultures were incubated with the bacteria for 30 min at 37°C in 5% CO2-95% 
air on a gyratory shaker at  100 rpm. At the end of the incubation, the monolayers were 
washed three times with RPMI 1640 medium (37°C) to remove non-monocyte-associated 
bacteria and incubated for an additional  1, 4, or 8 h in RPMI 1640 medium containing 
10%  of the same serum preparation  in  which they had been cultured before washing. 
The monolayers were then fixed and processed for electron microscopy as described (1). 
In studies on the effect oferythromycin  on fusion ofL. pneumophila-containing vacuoles 
with secondary lysosomes,  monocytes were preincubated with erythromycin (1.25 #g/ml) 
for 3 h  before infection, infected with L. pneumophila  in the presence of erythromycin 
(1.25 #g/ml), washed, incubated for 4 h additional in the presence of this concentration 
of erythromycin, and fixed for electron microscopy, as above. Control monocytes were 
treated in the same way but without erythromycin present. 
In studies on the effect of monocyte activation on fusion, monocytes were incubated 
with 40%  Concanavalin A-induced mononuclear cell supernatant,  supernatant control, 
or buffer control for 20 b at the same time that they were incubated with thorium dioxide. 
The cultures were then washed, incubated 3 h, infected, and again incubated for 1 h in 
the presence or absence of these supernatant  preparations as  indicated,  and fixed for 
electron  microscopy as  above.  Concanavalin A-induced mononuclear cell  supernatant 
was prepared by incubating 6 x  10  6 mononuclear cells at 37°C in 5%  CO~-95% air in 
35-mm plastic  petri  dishes  in  2  ml  RPMI  1640 medium containing 25%  fresh normal 2110  LEGIONELLA  PNEUMOPHILA  INHIBITS  PHAGOSOME-LYSOSOME  FUSION 
human serum and  15 #g/ml Concanavalin A for 48 h. At the end of the incubation, the 
cultures were transferred to conical tubes and the cells were sedimented by centrifugation 
at  200 g  for  10  min at  4°C.  The supernatant was  removed, filtered through  0.2-~m 
Millipore filters (Millipore Corp., Bedford, MA) and stored at -70°C. The supernatant 
control was prepared in the same way at the same time except Concanavalin A was added 
at the end of the 48-h incubation period rather than at the beginning. 
Assay  for Fusion of  L. pneumophila-containing Vacuoles with L  ysosomes Using Acid Phosphatase 
Q~,tochemistry.  Monocyte monolayers were prepared in plastic petri dishes exactly as in 
the above assay and then incubated 20 h at 37  C in 5% CO~-95% air in 2 ml RPMI 1640 
medium containing 15% fresh normal human serum. The cultures were then incubated 
with live or formalin-killed L. pneumophila (101° bacteria/mi) for 40 min on a gyratory 
shaker at 100 rpm. At the end of the incubation, the monolayers were washed three times 
with  RPMI  1640  medium  (37°C)  to  remove  non-monocyte-associated bacteria  and 
incubated at  37°C  in  5%  CO~-95%  air  for  1  h  additional  in  RPMI  1640  medium 
containing 10% fresh normal human serum. The monocyte monolayers were then fixed 
in 2.5% glutaraldehyde in 0.1  M cacodylate buffer, pH 7.4, at 0°C for 30 min, incubated 
in  0.88  M  sucrose at  0°C  for  15  min,  washed  in  0.9%  NaCI  (0°C),  incubated  with 
prewarmed and  filtered acid phosphatase  substrate  (37°C) for 40  rain,  washed  in  5% 
sucrose in 0.1 M cacodylate buffer (pH 7.4, 24°C), and processed for electron microscopy 
as described (1). The acid phosphatase substrate was prepared fresh and consisted of 25 
mg cytidine 5'-monophosphate (sodium salt);  12 ml double distilled water;  10 ml 0.05 M 
acetate buffer (pH 5.0); and 3 mt 1% lead nitrate, added in that order. Control substrate 
was prepared the same way but without cytidine 5'-monophosphate. This procedure is an 
amalgam of previously published procedures of Novikoff et al.,  Edelson and Cohn, and 
Muller et al. (19-21). 
Results 
L. pneumophila Inhibits Fusion of Phagosomes with Secondary Lysosomes.  Fusion of 
L. pneumophila-containing  intracellular vacuoles with monocyte secondary lyso- 
somes  was  examined  by  prelabeling  the  lysosomes  with  thorium  dioxide,  an 
electron-opaque colloidal marker (3). The best results were obtained with 6.25 
#1  thorium  dioxide/ml;  12.5  #l/mi  was  satisfactory  but  25  ul/ml  resulted  in 
monocytes engorged with label. After the monocyte lysosomes were labeled, the 
monocytes were  infected,  incubated,  and  fixed as  described  in  Materials  and 
Methods. The monocytes were then examined by electron microscopy to deter- 
mine how many L. pneumophila--containing  vacuoles had fused with lysosomes 
containing thorium dioxide. 
In normal monocytes infected and incubated with live L. pneumophila for 1 h, 
few L. pneumophila-containing vacuoles were fused with thorium dioxide-labeled 
lysosomes (Table  I,  lines  a,  b,  and j;  Fig.  1,  A-C).  Of a  total  of 88  vacuoles 
examined with  the 2  concentrations of thorium dioxide presented in Table  I, 
only  3  (3%)  were  positive  for thorium  dioxide.  Of the  95  bacteria  in  these 
vacuoles, only 4 (3%) were in vacuoles positive for thorium dioxide. 
In  contrast,  in  normal  monocytes incubated with  formalin-killed L. pneumo- 
phila,  a  majority  of the  L.  pneumophila-containing  vacuoles  were  fused  with 
thorium dioxide-labeled iysosomes (Table I, lines g and h; Fig. 2, A and B). Of a 
total of 159 vacuoles,  120 (75%) were positive for thorium dioxide. Of the 311 
bacteria  in  these  vacuoles,  264  (85%)  were  in  vacuoles  positive  for  thorium 
dioxide. Vacuoles containing formalin-killed L. pneumophila frequently contained 
more than  1 bacterium (1-12), whereas vacuoles containing live L. pneumophila 
only occasionally had more than  1 bacterium and then only 2 bacteria. T
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In addition to formalin-killed L. pneumophila,  live S. pneumoniae and live E. coli 
were used as controls (Table I;  Fig.  2,  C and D). As with vacuoles containing 
formalin-killed L. pneumophila,  the majority of vacuoles containing S. pneumoniae 
(67%) or E.  coil (92%) were positive for thorium dioxide; the positive vacuoles 
contained 78% of all S. pneumoniae and 93% of all E. coil in vacuoles. 
Fusion was also examined later after entry of L. pneumophila  into monocytes 
at a  time when the ribosome-lined vacuole was forming or formed; (Table I, 
lines c, d, and m; Fig.  1  D). At both 4 and 8 h after entry, few L. pneumophila- 
containing vacuoles were fused. Of a total of 53 vacuoles containing 57 bacteria 
at 4 h, only 1 vacuole containing 1 bacterium was positive for thorium dioxide. 
Of 29 vacuoles containing 38 L. pneumophila examined at 8 h, none were positive 
for thorium dioxide. The majority of these vacuoles, 71% at 4 h and 90% at 8 
h, were studded with ribosomes. 
Influence of Antibody and Complement on Fusion of L. pneumophila Phagosomes with 
Secondary Lysosomes.  In studies discussed thus far, monocytes were infected with 
L.  pneumophila  in  the  presence of a  source of complement alone.  However, 
antibody markedly affects both  phagocytosis and  killing of L. pneumophila  by 
monocytes (22). In the presence of complement alone, phagocytosis is relatively 
inefficient and monocytes do not kill or kill an insignificant proportion of an 
inoculum of L. pneumophila  (22).  In contrast, in the presence of both antibody 
and complement, phagocytosis of L. pneumophila is very efficient and monocytes 
kill approximately half of an inoculum of L. pneumophila; the surviving bacteria 
multiply in the monocytes (22). Therefore, the influence of both antibody and 
complement on fusion of L. pneumophila  phagosomes with secondary lysosomes 
was studied.  Live L.  pneumophila  were pretreated with  fresh immune human 
serum containing high-titer anti-L, pneumophila  antibody and complement and 
thorium dioxide-treated monocytes were infected with  these  bacteria in  the 
presence of both antibody and complement. 
Antibody significantly promoted fusion (Fig. 3). In Experiment I, in monocytes 
pretreated with either 6.25  or  12.5  #l/ml thorium dioxide and then infected 
with L. pneumophila in the presence of both antibody and complement, 15 (19%) 
of 79  L.  pneumophila-containing  vacuoles  were positive  for  thorium  dioxide 
FIGURE  1.  L.  pneumophila phagosomes  do  not  fuse  with  monocyte  secondary  lysosomes. 
Freshly explanted monocytes in monolayer culture were preincubated with thorium dioxide 
and then incubated with live L. pneumophila in the presence of fresh normal human serum for 
30 min, as described in Materials and Methods. Afterwards, the monocyte monolayers were 
washed to remove non-monocyte associated bacteria, incubated for an additional 1, 4, or 8 h, 
and processed for electron microscopy. (A-C) At 1 h, L. pneumophila phagosomes (arrows) are 
found in the vicinity of thorotrast-labeled secondary lysosomes (L) in some monocytes (A and 
B) and apparently at a  distance from prelabeled lysosomes in other monocytes (C).  The L. 
pneumophila phagosome  in  B  is  shown  at  higher  magnification  in  A.  The  phagosome  is 
surrounded  by  smooth  vesicles and  by  a  mitochondrion  closely apposed  to  the  vacuolar 
membrane;  these features are characteristic of the L. pneumophila phagosome at this point 
after infection (1).  There is no thorium dioxide within the phagosome,  indicating that  the 
phagosome has not fused with thorium dioxide-labeled secondary lysosomes. A, x  16,700; B, 
x  8,300;  C, x  8,400.  (D) At 4  h, the L. pneumophila phagosome is studded with ribosomes 
(arrow heads), a  characteristic of the L. pneumophila phagosome at this point after infection 
(1). As at 1 h, phagosomes at 4 h and 8 h typically are not fused with secondary lysosomes, x 
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(Table I, lines e and f); the positive vacuoles contained 20% of all bacteria. This 
was a significant increase over the percentage of positive vacuoles (2% i.e.,  1 in 
61 vacuoles) in monocytes infected with L. pneumophila and incubated for 1 h in 
the presence of complement alone (Table  I,  lines a  and b).  In Experiment II, 
28% of vacuoles containing 33% of the bacteria were positive in the presence of 
both antibody and complement, whereas only 7%  of vacuoles were positive in 
the presence of complement alone (Table I, linesj and l). Of vacuoles that were 
fused with lysosomes in the presence of antibody and complement, about half 
resembled  vacuoles  containing  formalin-killed  L.  pneumophila (1)  in  that  no 
cytoplasmic organelles surrounded the vacuoles (Fig. 3, B and C). The other half 
resembled  vacuoles containing live L.  pneumophila (1)  in  that  smooth vesicles 
and/or mitochondria were clustered about the vacuoles. 
In the presence of antibody alone, as in the presence of complement alone, 
monocytes do not phagocytose L. pneumophila as efficiently as in the presence of 
both antibody and complement, and they do not kill a significant proportion of 
a  bacterial  inoculum (20).  The  influence of antibody alone was examined by 
pretreating live L. pneumophila with heat-inactivated immune human serum, a 
source of antibody alone, and then infecting monocytes with these bacteria. 
Again, antibody significantly promoted fusion. In Experiment II (Table I, line 
k),  with  antibody  alone,  38%  of  the  vacuoles  contained  thorium  dioxide,  a 
proportion comparable to and somewhat greater than that found in the presence 
of both antibody and complement in the same experiment. Similarly, in Experi- 
ment III (Table II), antibody alone (line k), or antibody and complement (line l) 
resulted in increased proportions of fused vacuoles (21% and 32%, respectively) 
in comparison to control levels (10% and 14%; linesfand h). 
Thus, although phagocytosis of L. pneumophila is less efficient in the presence 
of antibody  alone  than  in  the  presence  of both  antibody  and  complement, 
comparable proportions of those bacteria that are ingested end up in vacuoles 
fused with secondary lysosomes. 
FIGURE 2.  Phagosomes containing formalin-killed L. pneumophila,  live encapsulated E.  coli, 
and live S. pneumoniae  fuse with monocyte secondary lysosomes. Monocytes were cultured and 
preincubated  with thorium  dioxide as in Fig.  1.  The  monocytes were then  incubated with 
formalin-killed L. pneumophila,  live unencapsulated S. pneumoniae,  or live encapsulated E. coli 
in  the  presence  of fresh  normal  human  serum  for  30  rain  as described  in  Materials and 
Methods. Afterwards, the monocytes were washed to remove non-monocyte-associated bac- 
teria,  incubated  for an  additional  1 h,  and  processed  for  electron  microscopy. (A)  Three 
phagosomes (arrows) containing 1, 2, and 3 formalin-killed L. pneumophila  are present in this 
region  of monocyte  cytoplasm.  The  phagosomes  with  1  and  3  bacteria  have  fused  with 
secondary lysosomes as evident by the presence of electron-opaque contrast material (thorium 
dioxide) within them. x  27,300.  (B) Four phagosomes (arrows) containing formalin-killed L. 
pneumophila  are present in this region of the monocyte cytoplasm; three phagosomes contain 
1 bacterium each and one large phagosome contains 11 bacteria in this thin section. The large 
phagosome and two of the three small ones have fused with secondary lysosomes; only a little 
thorium dioxide is evident in the small phagosome at the base of the monocyte. The uppermost 
small phagosome, located near the nucleus, does not contain thorium dioxide, x  15,800. (C) 
Three large phagosomes (arrows) containing S. pneumoniae  are present in this region of the 
monocyte. All three phagosomes have fused with secondary  lysosomes, x  14,600.  (D) This 
phagosome contains a  single encapsulated E.  coil and has fused with secondary lysosomes, x 
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h~uence of Erythromycin on Fusion of L. pneumophila Phagosomes with Secondary 
Lysosomes.  Erythromycin (1.25  ug/ml), a  potent inhibitor of bacterial protein 
synthesis, inhibits the intracellular multiplication of L. pneumophila within 1 h of 
addition to monocytes containing bacteria in the midlogarithmic phase of growth 
(23).  The antibiotic-inhibited L. pneumophila are not killed by the monocytes. 
Upon removal of the antibiotic, these bacteria resume multiplying (23).  Eryth- 
romycin has no apparent effect on the formation of the L. pneumophila vacuole 
(1). The influence of erythromycin on fusion of L. pneumophila phagosomes with 
secondary lysosomes was examined by infecting monocytes with L. pneumophila 
and incubating the cultures for 4 h in the presence or absence of erythromycin, 
as described in Materials and Methods. 
Erythromycin had little if any effect on phagosome-lysosome fusion (Table I, 
lines m and n).  In the presence of erythromycin, 9% of vacuoles were positive 
for  thorium  dioxide.  In  the  absence  of erythromycin, 4%  of vacuoles  were 
positive. 
Influence of Monocyte Activation on  Fusion of L.  pneumophila Phagosomes with 
Secondary Lysosomes.  Activated monocytes inhibit the intracellular multiplication 
of L. pneumophila (24, 25). Therefore, the influence of monocyte activation on 
fusion was studied by activating monocytes with Concanavalin A-induced mono- 
nuclear cell supernatants before infecting them with L. pneumophila. 
Activation  of  monocytes promoted  fusion  of phagosomes  with  secondary 
lysosomes to a small degree (Table II; Fig. 4).  In Experiment I,  16%  and  14% 
of vacuoles in supernatant-treated monocytes incubated with 6.25 or 12.5 #l/ml 
thorium dioxide, respectively, were fused (lines a and c) compared with 3% and 
0% of vacuoles in untreated monocytes (lines b and d). In Experiment III, 28% 
of vacuoles in supernatant-treated monocytes were fused (line e) compared with 
14%  of vacuoles in monocytes treated with supernatant control (line f). Similar 
results were obtained when monocytes were incubated with these supernatant 
preparations for 20 h, washed, and incubated without the supernatant prepara- 
tions for 3 h  before and during the infection (lines g and h).  Interestingly, of 
vacuoles in activated monocytes that were fused with lysosomes, nearly all (>90%) 
resembled vacuoles containing live L. pneumophila at  1 h  after infection (1)  in 
that smooth vesicles and/or mitochondria were clustered about the vacuoles (Fig. 
4a-c). 
L.  pneumophila Phagosomes Do Not  Fuse with Primary or Secondary Lysosomes. 
FIGURE 3.  Fusion of L. pneumophila phagosomes with monocyte secondary lysosomes is 
promoted by coating  the bacteria with antibody  andcomplement.  Monocytes  were cultured, 
preincubated with thorium dioxide, infected,  washed, incubated for 1 h, and processed for 
electron microscopy as in Fig. 1 except that the monocytes were incubated with live L. 
pneumophila pretreated  with human  anti-L, pneumophila  antibody  and complement.  (A) At least 
four phagosomes  containing  antibody-  and complement-coated  L. pneumophila  are present in 
this cross section of the monocyte  (arrows); three phagosomes  contain 1 bacterium  each and 
one phagosome contains 2 bacteria. The two lower phagosomes have fused with secondary 
lysosomes,  x 11,100. (B and C) Two phagosomes  in A  that have  fused  with  secondary  lysosomes 
are shown at higher magnification.  The phagosomes are not surrounded by either smooth 
vesicles or mitochondria  closely  apposed to the phagosome membrane. B, x  25,000; C, x 
16,700. T
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FIGURE 4.  Activating monocytes promotes fusion of a small proportion of phagosomes with 
monocyte secondary lysosomes. Monocytes were cultured as in Figs. 1-3 except that in addition 
to thorium dioxide they were incubated for 20 h with Concanavalin A-induced mononuclear 
cell supernatants to activate them. The monocytes were then infected, washed, incubated for 
1 h, and processed for electron microscopy as in Fig. 1. (A) The phagosome has fused with 
thorium dioxide-labeled secondary  lysosomes. The phagosome  is surrounded by smooth 
vesicles and 5 mitochondria closely apposed to the phagosome membrane. ×  14,300. (B) The 
phagosome has fused with secondary lysosomes. Smooth vesicles line segments of the phago- 
some  membrane (arrows).  x  23,300.  (C)  Two phagosomes  are  present in this  region of 
monocyte  cytoplasm. Both have fused with secondary lysosomes; the larger phagosome contains 
only a little thorium dioxide  (arrow). Both phagosomes are lined by smooth  vesicles and at 
least 1 mitochondrium, x  17,900. 
TABLE  III 
Study of Fusion between L. pneumophila Phagosomes  and Monocyte Lysosomes by Acid Phosphatase 
Cytochemistr), 
Bacterial particle  CMP 
No. mono-  No. vacu-  Vacuoles positive for acid  No. bacte-  Bacteria in positive vacu- 
cytes exam-  oles contain-  phosphatase  ria in vac-  oles 
ined  ing bacteria  No.  %  uoles  No.  % 
a.  L.p.eumophila,  +  78  78  8  10%  79  8  10% 
live 
b.  L.p.eumophila,  -  21  28  0  0%  28  0  0% 
live 
c.  L. pneumophila,  +  62  76  64  84%  271  243  90% 
formalin-killed 
d.  L.p.ru.lophila.  -  20  51  0  0%  148  0  0% 
formalin-killed 
Freshly explanted monocytes in monolayer culture were incubated for 20 h at 37°C in 5% CO~-95% air in 
35-mm petri dishes in 2 ml RPMI  1640 medium containing 15% fresh normal human serum. The cultures 
were  then incubated on a gyratory shaker  for 40  rain with  101° live or formalin-killed L. pneumophila, 
washed to remove non-monocyte-associated  bacteria, and incubated for an additional 1 h. The monolayers 
were  then  gently fixed  with  glutaraldehyde and  incubated with  complete  acid  phosphatase  substrate 
containing cytidine 5'-monophosphate (CMP+), or incomplete acid phosphatase  substrate  not containing 
cytidine 5'-monophosphate (CMP--), and lead nitrate as the capture reagent. The monolayers were then 
processed for electron microscopy. 
Although phagosomes containing live L. pneumophila do not fuse with secondary 
lysosomes, these experiments do not exclude fusion with primary lysosomes. This 
was investigated next by staining the  vacuole for acid phosphatase,  an enzyme 
found  in  monocyte  lysosomes.  Monocytes  were  infected  with  L.  pneumophila, 2120  LEGIONELLA  PNEUMOPHILA  INHIBITS  PHAGOSOME-LYSOSOME FUSION HORWITZ  2121 
gently fixed, and stained for acid phosphatase, using cytidine 5'-monophosphate 
as substrate and lead nitrate as the capture reagent, as described  in  Materials 
and Methods. The L. pneumophila-containing vacuoles were then examined for 
the presence of acid phosphatase, as indicated by the presence of electron-opaque 
lead phosphate reaction product. 
In monocytes infected and incubated with live L. pneumophila for  1 h, few L. 
pneumophila-containing vacuoles had fused with lysosomes, i.e. few phagosomes 
contained lead phosphate reaction product in the space between the bacteria and 
phagosome membrane (Table III;  Fig. 5, A-C). Of 78 vacuoles examined, only 
10%  were  positive  for  acid  phosphatase  (line  a).  In  contrast,  in  monocytes 
incubated with formalin-killed L. pneumophila, 84% of vacuoles were fused (Table 
III, line c; Fig. 5D). Control monocytes in the absence of cytidine 5'-monophos- 
phate substrate were uniformly negative (lines b and d). 
Interestingly,  79% of live L. pneumophila in vacuoles negative for acid phos- 
phatase in the space betweeen the bacterial surface and the vacuolar membrane 
had a thin layer of lead phosphate reaction product between the inner and outer 
bacterial membranes (Fig. 5, A-C). This thin layer was absent in control prepa- 
rations  in  which the  cytidine  5'-monophosphate  substrate  was  omitted.  The 
reaction product indicates the presence of a bacterial acid phosphatase, presum- 
ably located in the periplasmic space. 
Thus,  phagosomes  containing  live  L.  pneumophila do  not  fuse  with  either 
primary or secondary lysosomes. 
FIGURE 5.  Interactions between L. pneumophila phagosomes and lysosomes as studied by acid 
phosphatase  cytochemistry.  Monocytes  in  monoiayer culture  were  incubated  with  live or 
formalin-killed L. pneumophila for 40 min, washed to remove non-monocyte-associated bac- 
teria,  and  incubated  for an  additional  1  h.  The  monolayers were  then  gently  fixed with 
glutaraldehyde,  stained  for acid phosphatase  using cytidine 5'-monophosphate  as substrate 
and lead nitrate as capture reagent, and processed for electron microscopy, as described in 
Materials and Methods. (A) Four L. pneumophila phagosomes (arrows) are present in this cross 
section of a  monocyte infected with live L. pneumophila. None of the phagosomes has fused 
with lysosomes as evidenced by the absence of electron-opaque lead phosphate reaction product 
in the space between the bacteria and the phagosome membrane.  Lead phosphate  reaction 
product is present internal to the bacteria; this is seen at higher magnification in B and C. × 
13,700.  (B)  Three  L.  pneumophila phagosomes  (arrows)  are  present  in  this  region  of the 
cytoplasm of a monocyte infected with live L. pneumophila. The two lower phagosomes have 
not fused with lysosomes; as in A, lead phosphate reaction product is located internal to the 
bacteria but not in the space between the bacteria and phagosome membrane. In contrast, the 
upper phagosome has fused with lysosomes as evidenced by the presence of electron opaque 
lead  phosphate  reaction  product  in  the  space  between  the  bacteria  and  the  phagosome 
membrane. In monocytes infected with live L. pneumophila, few phagosomes were found fused 
with lysosomes, x  23,700.  (C) This is a high magnification of a L. pneumophita phagosome in 
a monocyte infected with live L. pneumophila. The phagosome has not fused as evidenced by 
the absence of lead phosphate reaction product in the space between the bacterium and the 
phagosome  membrane.  However,  reaction  product  is  present  internal  to  the  bacterium 
between the inner and outer bacterial membranes (arrows). This indicates the presence of a 
bacterial acid phosphatase, presumably located in the periplasmic space, x  91,000. (D) One L. 
pneumophila phagosome (arrow) is present in this cross-section of a monocyte incubated with 
formalin-killed L.  pneumophila. As  is  typical  of phagosomes  containing  formalin-killed L. 
pneumophila, this phagosome has fused with lysosomes, x  13,700. 2122  LEGIONELLA  PNEUMOPHILA  INHIBITS PHAGOSOME-LYSOSOME  FUSION 
Discussion 
This  study demonstrates that  L.  pneumophila belongs  to  a  select group  of 
intracellular parasites  whose  phagosomes  do  not  fuse  with  iysosomes.  These 
parasites include the human pathogens M. tuberculosis (3 and 4), T. gondii (2), and 
C. psittaci (6).  In  the case of these other human pathogens,  mouse peritoneal 
macrophages or mouse cell lines were used in  studies of phagosome-lysosome 
fusion. In this study, human monocytes were used and L. pneumophila phagosomes 
were found not to fuse with either primary or secondary lysosomes of human 
monocytes. 
In addition to a  capacity to inhibit phagosome-lysosome fusion, phagosomes 
containing C.  psittaci and  T.  gondii share with L.  pneumophila certain  unusual 
morphologic  features.  The  phagosomes  are  surrounded  by  smooth  vesicles, 
mitochondria, or ribosomes closely apposed to the phagosomal membrane (1). 
This suggests that a common mechanism may underlie the cytoplasmic reaction 
about the phagosomes and the capacity to inhibit phagosome-lysosome fusion. 
Formalin-killed  L.  pneumophila  do  not  share  with  live  L.  pneumophila  the 
capacity to inhibit fusion. This suggests that a surface structure is not responsible 
for the inhibition of fusion by live bacteria unless such a  structure is critically 
altered by formalin treatment. However, formalin treatment does not eliminate 
L. pneumophila's  capacity to  induce proliferation and production of monocyte 
activating cytokines by lymphocytes from patients recovered from Legionnaires' 
disease (25).  Also, formalin-treated L. pneumophila are recognized about as well 
as heat-killed L. pneumophila by anti-L, pneumophila antibody in immune human 
serum (26). As with formalin-killed L. pneumophila, glutaraidehyde-fixed T. gondii 
(2) and heat-killed C. psittaci (6) fail to inhibit phagosome-lysosome fusion. 
Erythromycin, a potent inhibitor of bacterial protein synthesis, at concentra- 
tions that completely inhibit intraceilular multiplication of L. pneumophila, has 
no effect on phagosome-lysosome fusion. This suggests that ongoing bacterial 
protein synthesis is not required for inhibition of fusion. Similarly, chlox:amphen- 
icol, a  potent  inhibitor  of chlamydial protein  synthesis was found to  have no 
apparent effect on C. psittaci inhibition of phagosome-lysosome fusion (6). 
Coating  live  L.  pneumophila  with  antibody,  with  or  without  complement, 
promotes fusion with  lysosomes of a  proportion  of the bacterial phagosomes. 
Antibody has also been reported to promote fusion with lysosomes ofphagosomes 
containing M.  tuberculosis (27),  T. gondii (28), C. psittaci (6),  and E.  cuniculi (8). 
The  fact  that  antibody and  complement also  promote  monocyte killing of a 
proportion (~50%) of an inoculum of L. pneumophila, taken together with the 
fact that formalin-killed L. pneumophila are found in fused phagosomes, suggests 
that the antibody and complement-coated bacteria that are killed are the ones 
found in  fused phagosomes.  If so,  then  the study does not indicate whether 
fusion precedes or follows bacterial death. 
Activation of the monocytes also promoted fusion of a small proportion of L. 
pneumophila phagosomes. In vivo activation of mouse macrophages has also been 
reported to promote fusion of lysosomes with yeast-containing phagosomes (29). 
The L. pneumophila phagosomes that had fused were virtually always surrounded 
by smooth vesicles and/or mitochondria, a  hallmark of phagosomes containing 
live bacteria  1 h after entry into monocytes (1).  This suggests that the bacteria HORWITZ  2123 
were still  alive or alive for a  substantial  proportion  of their first hour in  the 
monocyte. What relationship phagosome-lysosome fusion has to the capacity of 
activated monocytes to inhibit L. pneumophila intracellular multiplication is not 
clear from this study. It is possible that bacteria in fused phagosomes are killed 
or inhibited from multiplying. However, only a small proportion of phagosomes 
in activated monocytes are fused at 1 h after infection. Thus, it is not clear that 
phagosome-lysosome fusion in  activated monocytes is  sufficiently extensive to 
account for the strong inhibition of L. pneumophila multiplication. 
The mechanism by which intracellular parasites inhibit phagosome-lysosome 
fusion is unknown. Moreover, although this phenomenon is commonly referred 
to as inhibition of phagosome-lysosome fusion, it is not known whether all such 
parasites possess an inhibitory factor per se or lack a fusion-promoting factor. In 
the case of M.  tuberculosis, two  fusion inhibitory factors have been suggested. 
First,  sulfatides of M.  tuberculosis (anionic trehalose glycolipids), which share a 
polyanionic character with substances  that  inhibit phagosome-lysosome fusion 
(30),  were suspected of playing an antifusion role (31).  These sulfatides, when 
taken up into secondary lysosomes of mouse macrophages or when attached to 
target yeast particles before ingestion by mouse macrophages, were found to 
inhibit  fusion  of secondary lysosomes  with  yeast-containing phagosomes(31). 
Second,  ammonia production  by M.  tuberculosis was  suspected  of playing an 
antifusion role when filtrates from cultures of tubercule bacilli, which contain 
high concentrations of ammonia, were found to inhibit fusion of mouse macro- 
phage secondary lysosomes with  yeast-containing phagosomes (32).  Ammonia 
was found to mimic the antifusion effect of the culture filtrates and the ammonia 
content of the filtrates appeared sufficient to account for their antifusion effect 
(32).  Whether L. pneumophila or other intracellular parasites possess antifusion 
substances or have the capacity to release large amounts of ammonia or other 
amines that may exert an antifusion effect remains to be determined. 
The high correlation between monocyte killing of L. pneumophila and phago- 
some-lysosome fusion--both increased in the presence of antibody and comple- 
ment-suggests  the possibility  that  inhibition  of fusion  may be an  important 
mechanism by which L. pneumophila resists host cell microbicidal agents. Further 
evidence for this comes from studies of the susceptibility of L. pneumophila to 
oxygen metabolites, in particular hydrogen peroxide, generated by phagocytes. 
In the presence of myeloperoxidase and a halide, L. pneumophila is susceptible to 
killing by concentrations of hydrogen peroxide to which it is otherwise resistant 
(33, 34). Similarly, in the presence of lactoperoxidase and a halide, the concen- 
tration of hydrogen peroxide that kills 50% of an inoculum of L. pneumophila is 
reduced by 100-fold (M. A. Horwitz, unpublished data). Therefore, one-way by 
which  inhibition  of phagosome-lysosome fusion  may enhance L.  pneumophila 
survival in monocytes and perhaps polymorphonuclear leukocytes is by blocking 
access of lysosomai or granule myeloperoxidase to the L. pneumophila phagosome, 
thereby protecting the bacterium from otherwise lethal concentrations of hydro- 
gen peroxide generated by the phagocyte. 
Summary 
The interactions between the L. pneumophila phagosome and monocyte lyso- 
somes were investiga~d by prelabeling the lysosomes with thorium dioxide, an 2124  LEGIONELLA PNEUMOPHILA INHIBITS PHAGOSOME-LYSOSOME FUSION 
electron-opaque colloidal marker, and by acid phosphatase cytochemistry. 
Phagosomes containing  live L. pneumophila did not fuse with secondary lyso- 
somes at  1 h after entry into monocytes or at 4 or 8 h after entry by which time 
the ribosome-lined L. pneumophila  replicative vacuole had formed.  In contrast, 
the majority of phagosomes containing formalin-killed L. pneumophila, live Strep- 
tococcus pneumoniae,  and live Escherichia  coli had fused with secondary lysosomes 
by 1 h after entry into monocytes. 
Erytbromycin, a potent inhibitor of bacterial protein synthesis, at a concentra- 
tion that completely inhibits L. pneumophila intracellular  multiplication,  had no 
influence  on  fusion  of L.  pneumophila  phagosomes  with  secondary  iysosomes. 
However, coating live L. pneumophila with antibody or with antibody and com- 
plement partially overcame the inhibition of fusion. Also activating the monocytes 
promoted fusion of a  small proportion  of phagosomes containing  live L.  pneu- 
mophila  with secondary lysosomes. 
Acid phosphatase cytochemistry revealed that phagosomes containing  live L. 
pneumophila did not fuse with either primary or secondary lysosomes. In contrast 
to phagosomes containing  live bacteria,  the majority of phagosomes containing 
formalin-killed  L.  pneumophila  were fused with  lysosomes by acid phosphatase 
cytochemistry. 
The capacity of L. pneumophila to inhibit phagosome-lysosome fusion may be 
a  critical  mechanism  by  which  the  bacterium  resists  monocyte  microbicidal 
effects. 
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